Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T51076 | Target Info | |||
Target Name | NT-3 growth factor receptor (TrkC) | ||||
Synonyms |
TrkC tyrosine kinase; Trk-C; TRKC; Neurotrophic tyrosine kinase receptor type 3; NT3 growth factor receptor; GP145TrkC; GP145-TrkC
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | NTRK3 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Tropomyosin-related kinase A (TrkA) | Successful Target | ||||
UniProt ID | NTRK1_HUMAN | |||||
Gene Name | NTRK1 | |||||
Synonyms |
gp140trk; Tyrosine kinase receptor A; Tyrosine kinase receptor; Trk-A; TRKA; TRK1-transforming tyrosine kinase protein; TRK1 transforming tyrosinekinase protein; TRK; P140-TrkA; Neurotrophic tyrosine kinase receptor type 1; NGF-trk receptor type A; MTC; High affinity nerve growth factor receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 0.22 nM | Click to Show More | [1] | |
2 | Altiratinib | Drug Info | IC50 = 0.85 nM | [3] | ||
3 | Larotrectinib | Drug Info | IC50 = 2 nM | [4] | ||
4 | MK-2461 | Drug Info | IC50 = 46 nM | [8] | ||
Co-Target Name | Proto-oncogene c-Met (MET) | Successful Target | ||||
UniProt ID | MET_HUMAN | |||||
Gene Name | MET | |||||
Synonyms |
Tyrosine-protein kinase Met; Scatter factor receptor; SF receptor; Met proto-oncogene tyrosine kinase; Hepatocyte growth factor receptor; HGF/SF receptor; HGF-SF receptor; HGF receptor; C-met; C-Met receptor tyrosine kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | MK-2461 | Drug Info | IC50 = 0.4 nM | Click to Show More | [2] | |
2 | Altiratinib | Drug Info | IC50 = 2.7 nM | [3] | ||
Co-Target Name | BDNF/NT-3 growth factors receptor (TrkB) | Successful Target | ||||
UniProt ID | NTRK2_HUMAN | |||||
Gene Name | NTRK2 | |||||
Synonyms |
Tropomyosin-related kinase B; TrkB tyrosine kinase; Trk-B; TRKB; Neurotrophic tyrosine kinase receptor type 2; GP145-TrkB
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 3 nM | Click to Show More | [5] | |
2 | Altiratinib | Drug Info | IC50 = 4.6 nM | [3] | ||
3 | Larotrectinib | Drug Info | IC50 = 5.21 nM | [6] | ||
4 | MK-2461 | Drug Info | IC50 = 61 nM | [8] | ||
Co-Target Name | Proto-oncogene c-Ros (ROS1) | Successful Target | ||||
UniProt ID | ROS1_HUMAN | |||||
Gene Name | ROS1 | |||||
Synonyms |
c-Ros receptor tyrosine kinase; Receptor tyrosine kinase c-ros oncogene 1; ROS; Proto-oncogene tyrosine-protein kinase ROS; Proto-oncogene c-Ros-1; MCF3
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 5 nM | [5] | ||
Co-Target Name | ALK tyrosine kinase receptor (ALK) | Successful Target | ||||
UniProt ID | ALK_HUMAN | |||||
Gene Name | ALK | |||||
Synonyms |
CD246; Anaplastic lymphoma kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | Ki = 6.2 nM | [5] | ||
Co-Target Name | Vascular endothelial growth factor receptor 2 (KDR) | Successful Target | ||||
UniProt ID | VGFR2_HUMAN | |||||
Gene Name | KDR | |||||
Synonyms |
VEGFR2; VEGFR-2; VEGF-2 receptor; Protein-tyrosine kinase receptor flk-1; Kinase insert domain receptor; Fetal liver kinase 1; FLK1; FLK-1; CD309
Click to Show/Hide
|
|||||
Representative Drug(s) | Altiratinib | Drug Info | IC50 = 9.2 nM | Click to Show More | [7] | |
2 | MK-2461 | Drug Info | IC50 = 44 nM | [8] | ||
3 | Entrectinib | Drug Info | IC50 ~ 1000 nM | [5] | ||
Co-Target Name | Fms-like tyrosine kinase 3 (FLT-3) | Successful Target | ||||
UniProt ID | FLT3_HUMAN | |||||
Gene Name | FLT3 | |||||
Synonyms |
Stem cell tyrosine kinase 1; STK1; STK-1; Receptor-type tyrosine-protein kinase FLT3; Fetal liver kinase-2; FLT-3; FLK2; FLK-2; FL cytokine receptor; CD135
Click to Show/Hide
|
|||||
Representative Drug(s) | MK-2461 | Drug Info | IC50 = 22 nM | Click to Show More | [8] | |
2 | Entrectinib | Drug Info | IC50 = 164 nM | [5] | ||
Co-Target Name | Fibroblast growth factor receptor 2 (FGFR2) | Successful Target | ||||
UniProt ID | FGFR2_HUMAN | |||||
Gene Name | FGFR2 | |||||
Synonyms |
Keratinocyte growth factor receptor 2; Keratinocyte growth factor receptor; KSAM; KGFR; K-sam; FGFR-2; FGF-2 receptor; CD332; BEK
Click to Show/Hide
|
|||||
Representative Drug(s) | MK-2461 | Drug Info | IC50 = 39 nM | [8] | ||
Co-Target Name | Janus kinase 2 (JAK-2) | Successful Target | ||||
UniProt ID | JAK2_HUMAN | |||||
Gene Name | JAK2 | |||||
Synonyms |
Tyrosine-protein kinase JAK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 40 nM | Click to Show More | [5] | |
2 | MK-2461 | Drug Info | IC50 = 230 nM | [8] | ||
Co-Target Name | Fibroblast growth factor receptor 1 (FGFR1) | Successful Target | ||||
UniProt ID | FGFR1_HUMAN | |||||
Gene Name | FGFR1 | |||||
Synonyms |
c-fgr; bFGF-R-1; bFGF-R; N-sam; HBGFR; Fms-like tyrosine kinase 2; FLT2; FLT-2; FLG; FGFR-1; FGFBR; CEK; CD331 antigen; CD331; Basic fibroblast growth factor receptor 1; BFGFR
Click to Show/Hide
|
|||||
Representative Drug(s) | MK-2461 | Drug Info | IC50 = 65 nM | Click to Show More | [8] | |
2 | Entrectinib | Drug Info | IC50 ~ 1000 nM | [5] | ||
Co-Target Name | Platelet-derived growth factor receptor alpha (PDGFRA) | Successful Target | ||||
UniProt ID | PGFRA_HUMAN | |||||
Gene Name | PDGFRA | |||||
Synonyms |
RHEPDGFRA; Platelet-derived growth factor receptor 2; Platelet-derived growth factor alpha receptor; PDGFR2; PDGFR-alpha; PDGFR-2; PDGF-R-alpha; CD140a antigen; CD140a; CD140 antigen-like family member A; Alpha-type platelet-derived growth factor receptor; Alpha platelet-derived growth factor receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | MK-2461 | Drug Info | IC50 < 100 nM | [8] | ||
Co-Target Name | Janus kinase 1 (JAK-1) | Successful Target | ||||
UniProt ID | JAK1_HUMAN | |||||
Gene Name | JAK1 | |||||
Synonyms |
Tyrosine-protein kinase JAK1; JAK1B; JAK1A
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 112 nM | [5] | ||
Co-Target Name | Insulin-like growth factor I receptor (IGF1R) | Successful Target | ||||
UniProt ID | IGF1R_HUMAN | |||||
Gene Name | IGF1R | |||||
Synonyms |
Type 1 insulin-like growth factor receptor; Insulin-like growth factor 1 receptor; IGF-IR; IGF-I receptor; IGF-1R; IGF-1 receptor; CD221 antigen; CD221
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 122 nM | [5] | ||
Co-Target Name | Insulin receptor (INSR) | Successful Target | ||||
UniProt ID | INSR_HUMAN | |||||
Gene Name | INSR | |||||
Synonyms |
IR; CD220 antigen; CD220
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 209 nM | [5] | ||
Co-Target Name | Janus kinase 3 (JAK-3) | Successful Target | ||||
UniProt ID | JAK3_HUMAN | |||||
Gene Name | JAK3 | |||||
Synonyms |
Tyrosine-protein kinase JAK3; Leukocyte janus kinase; L-JAK
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 349 nM | [5] | ||
Co-Target Name | Proto-oncogene c-Ret (RET) | Successful Target | ||||
UniProt ID | RET_HUMAN | |||||
Gene Name | RET | |||||
Synonyms |
RET51; RET receptor tyrosine kinase; RET mutant Y791F; RET mutant V804M; RET mutant V804L; RET mutant S891A; RET mutant M918T; RET mutant G691S; Proto-oncogene tyrosine-protein kinase receptor Ret; PTC; Cadherin family member 12; CDHR16; CDHF12; C-ret
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 393 nM | Click to Show More | [5] | |
2 | MK-2461 | Drug Info | IC50 = 640 nM | [8] | ||
Co-Target Name | Tyrosine-protein kinase ABL1 (ABL) | Successful Target | ||||
UniProt ID | ABL1_HUMAN | |||||
Gene Name | ABL1 | |||||
Synonyms |
p150; Proto-oncogene tyrosine-protein kinase ABL1; Proto-oncogene c-Abl; JTK7; C-ABL; Abl; Abelson tyrosine-protein kinase 1; Abelson murine leukemia viral oncogene homolog 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Larotrectinib | Drug Info | IC50 ~ 1000 nM | Click to Show More | [6] | |
2 | Entrectinib | Drug Info | IC50 ~ 1000 nM | [5] | ||
Co-Target Name | Tyrosine-protein kinase Kit (KIT) | Successful Target | ||||
UniProt ID | KIT_HUMAN | |||||
Gene Name | KIT | |||||
Synonyms |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; p145 c-kit; Proto-oncogene tyrosine-protein kinase Kit; Proto-oncogene c-Kit; Piebald trait protein; PBT; Mast/stem cell growth factor receptor Kit; CD117 antigen; CD117; C-kit
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 ~ 1000 nM | [5] | ||
Co-Target Name | LCK tyrosine protein kinase (LCK) | Successful Target | ||||
UniProt ID | LCK_HUMAN | |||||
Gene Name | LCK | |||||
Synonyms |
p56-LCK; Tyrosine-protein kinase Lck; T cell-specific protein-tyrosine kinase; Proto-oncogene tyrosine-protein kinase LCK; Proto-oncogene Lck; Protein YT16; Lymphocyte cell-specific protein-tyrosine kinase; Leukocyte C-terminal Src kinase; LSK; LCK p59-Fyn; LCK Protooncogene Syn
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 ~ 1000 nM | [5] | ||
Co-Target Name | Tyrosine-protein kinase SYK (SYK) | Successful Target | ||||
UniProt ID | KSYK_HUMAN | |||||
Gene Name | SYK | |||||
Synonyms |
p72-Syk; Spleen tyrosine kinase
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 ~ 1000 nM | [5] | ||
Co-Target Name | Macrophage-stimulating protein receptor (RON) | Clinical trial Target | ||||
UniProt ID | RON_HUMAN | |||||
Gene Name | MST1R | |||||
Synonyms |
p185Ron; Proteintyrosine kinase 8; Macrophagestimulating protein receptor beta chain; Macrophagestimulating protein receptor; MST1R; MSP receptor; CDw136; CD136
Click to Show/Hide
|
|||||
Representative Drug(s) | MK-2461 | Drug Info | IC50 = 7 nM | [8] | ||
Co-Target Name | Angiopoietin 1 receptor (TEK) | Clinical trial Target | ||||
UniProt ID | TIE2_HUMAN | |||||
Gene Name | TEK | |||||
Synonyms |
hTIE2; VMCM1; VMCM; Tyrosine-protein kinase receptor TIE-2; Tyrosine-protein kinase receptor TEK; Tyrosine kinase with Ig and EGF homology domains-2; Tunica interna endothelial cell kinase; TIE2; P140 TEK; Endothelial tyrosine kinase; Endothelial Cell-Specific Receptor TIE-2; CD202b antigen; CD202b
Click to Show/Hide
|
|||||
Representative Drug(s) | Altiratinib | Drug Info | IC50 = 8 nM | [3] | ||
Co-Target Name | Vascular endothelial growth factor receptor 1 (FLT-1) | Clinical trial Target | ||||
UniProt ID | VGFR1_HUMAN | |||||
Gene Name | FLT1 | |||||
Synonyms |
Vascular permeability factor receptor; VEGFR1; VEGFR-1; VEGF-1 receptor; Tyrosine-protein kinase receptor FLT; Tyrosine-protein kinase FRT; Fms-like tyrosine kinase 1; FRT; FLT
Click to Show/Hide
|
|||||
Representative Drug(s) | MK-2461 | Drug Info | IC50 = 10 nM | [8] | ||
Co-Target Name | Tyrosine-protein kinase Mer (MERTK) | Clinical trial Target | ||||
UniProt ID | MERTK_HUMAN | |||||
Gene Name | MERTK | |||||
Synonyms |
Receptor tyrosine kinase MerTK; Proto-oncogene c-Mer
Click to Show/Hide
|
|||||
Representative Drug(s) | MK-2461 | Drug Info | IC50 = 24 nM | [8] | ||
Co-Target Name | Fibroblast growth factor receptor 3 (FGFR3) | Clinical trial Target | ||||
UniProt ID | FGFR3_HUMAN | |||||
Gene Name | FGFR3 | |||||
Synonyms |
JTK4; FGFR-3; CD333
Click to Show/Hide
|
|||||
Representative Drug(s) | MK-2461 | Drug Info | IC50 = 50 nM | [8] | ||
Co-Target Name | Vascular endothelial growth factor receptor 3 (FLT-4) | Clinical trial Target | ||||
UniProt ID | VGFR3_HUMAN | |||||
Gene Name | FLT4 | |||||
Synonyms |
VEGFR3; VEGFR-3; VEGF-3 receptor; Tyrosine-protein kinase receptor FLT4; Fms-like tyrosine kinase 4
Click to Show/Hide
|
|||||
Representative Drug(s) | MK-2461 | Drug Info | IC50 = 78 nM | Click to Show More | [8] | |
2 | Entrectinib | Drug Info | IC50 ~ 1000 nM | [5] | ||
Co-Target Name | Focal adhesion kinase 1 (FAK) | Clinical trial Target | ||||
UniProt ID | FAK1_HUMAN | |||||
Gene Name | PTK2 | |||||
Synonyms |
pp125FAK; p125FAK; Protein-tyrosine kinase 2; Protein phosphatase 1 regulatory subunit 71; PPP1R71; Focal adhesion kinase-related nonkinase; FRNK; FAK1; FADK 1; FADK
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 140 nM | [5] | ||
Co-Target Name | Tyrosine-protein kinase BRK (PTK6) | Clinical trial Target | ||||
UniProt ID | PTK6_HUMAN | |||||
Gene Name | PTK6 | |||||
Synonyms |
Protein-tyrosine kinase 6; Breast tumor kinase; BRK
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 195 nM | [5] | ||
Co-Target Name | Aurora kinase A (AURKA) | Clinical trial Target | ||||
UniProt ID | AURKA_HUMAN | |||||
Gene Name | AURKA | |||||
Synonyms |
hARK1; Serine/threonine-protein kinase aurora-A; Serine/threonine-protein kinase 6; Serine/threonine-protein kinase 15; Serine/threonine kinase 15; STK6; STK15; IAK1; Breast tumor-amplified kinase; BTAK; Aurora/IPL1-related kinase 1; Aurora-related kinase 1; Aurora-A; Aurora 2; AYK1; AURA; ARK1; ARK-1; AIRK1; AIK
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 215 nM | Click to Show More | [5] | |
2 | MK-2461 | Drug Info | IC50 = 290 nM | [8] | ||
Co-Target Name | Protein kinase C beta (PRKCB) | Clinical trial Target | ||||
UniProt ID | KPCB_HUMAN | |||||
Gene Name | PRKCB | |||||
Synonyms |
Protein kinase C beta type; PRKCB1; PKCB; PKC-beta; PKC-B
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 ~ 1000 nM | [5] | ||
Co-Target Name | Aurora kinase B (AURKB) | Clinical trial Target | ||||
UniProt ID | AURKB_HUMAN | |||||
Gene Name | AURKB | |||||
Synonyms |
Serine/threonine-protein kinase aurora-B; Serine/threonine-protein kinase 5; Serine/threonine-protein kinase 12; Serine/threonine protein kinase 12; STK5; STK12; Aurora/IPL1-related kinase 2; Aurora-related kinase 2; Aurora-B; Aurora-2 kinase; Aurora-2; Aurora- and Ipl1-like midbody-associated protein 1; Aurora 1; ARK2; ARK-2; AIRK2; AIM1; AIM-1; AIK2
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 ~ 1000 nM | [5] | ||
Co-Target Name | Activated CDC42 kinase 1 (ACK-1) | Patented-recorded Target | ||||
UniProt ID | ACK1_HUMAN | |||||
Gene Name | TNK2 | |||||
Synonyms |
Tyrosine kinase non-receptor protein 2; ACK1; ACK-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 70 nM | [5] | ||
Co-Target Name | Echinoderm microtubule associated protein like 4-ALK tyrosine kinase receptor fusion protein (EML4-ALK) | Co-Target | ||||
UniProt ID | EMAL4_HUMAN-ALK_HUMAN | |||||
Gene Name | EML4-ALK | |||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 = 28 nM | [5] | ||
Co-Target Name | Cyclin dependent kinase 2-Cyclin A2 complex (CDK2-CCNA2) | Co-Target | ||||
UniProt ID | CDK2_HUMAN-CCNA2_HUMAN | |||||
Gene Name | CDK2-CCNA2 | |||||
Representative Drug(s) | Entrectinib | Drug Info | IC50 ~ 1000 nM | [5] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA). Bioorg Med Chem Lett. 2019 Oct 1;29(19):126624. | ||||
REF 2 | Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs. Eur J Med Chem. 2016 Jan 27;108:495-504. | ||||
REF 3 | The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. J Med Chem. 2016 Oct 13;59(19):8712-56. | ||||
REF 4 | Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application. J Med Chem. 2019 Feb 28;62(4):1731-1760. | ||||
REF 5 | Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor. J Med Chem. 2016 Apr 14;59(7):3392-408. | ||||
REF 6 | Design, synthesis and biological evaluation of 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-2-methylbenzamides as potent and selective pan-tropomyosin receptor kinase (TRK) inhibitors. Eur J Med Chem. 2019 Oct 1;179:470-482. | ||||
REF 7 | Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2. Eur J Med Chem. 2018 Oct 5;158:814-31. | ||||
REF 8 | Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer. J Med Chem. 2011 Jun 23;54(12):4092-108. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.